Cargando…

Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer

BACKGROUND: High-grade serous ovarian cancer (HGSOC) is the most common and lethal subtype of ovarian cancer. A growing body of evidence suggests tumor-supporting roles of several members of the kallikrein-related peptidase (KLK) family, including KLK5 and KLK7, in this cancer subtype. In normal phy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Weiwei, Liu, Yueyang, Diamandis, Eleftherios P., Kiechle, Marion, Bronger, Holger, Dorn, Julia, Dreyer, Tobias, Magdolen, Viktor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579813/ https://www.ncbi.nlm.nih.gov/pubmed/33087135 http://dx.doi.org/10.1186/s13048-020-00725-5

Ejemplares similares

Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients
por: Gong, Weiwei, et al.
Publicado: (2019)

Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2019)

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
por: Schmitt, Manfred, et al.
Publicado: (2013)

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
por: Gong, Weiwei, et al.
Publicado: (2020)

Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer
por: Geng, Xiaocong, et al.
Publicado: (2017)

A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression
por: Liu, Yueyang, et al.
Publicado: (2022)

Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer
por: Wang, Ping, et al.
Publicado: (2018)

Aberrant expression of kallikrein‐related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion
por: Delaunay, Tiphaine, et al.
Publicado: (2017)

Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
por: Tamir, Ayala, et al.
Publicado: (2014)

Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency
por: Silva, Lakmali Munasinghage, et al.
Publicado: (2017)

Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
por: Goettig, Peter, et al.
Publicado: (2010)

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
por: Goldhardt, Oliver, et al.
Publicado: (2019)

Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 – KLK9), using Next-generation sequencing
por: Adamopoulos, Panagiotis G., et al.
Publicado: (2017)

Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker
por: Sato, Ai, et al.
Publicado: (2023)

Structural basis for the Zn(2+) inhibition of the zymogen-like kallikrein-related peptidase 10
por: Debela, Mekdes, et al.
Publicado: (2016)

Kallikrein-related peptidase-4 (KLK4): role in enamel formation and revelations from ablated mice
por: Bartlett, John D., et al.
Publicado: (2014)

Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status
por: Fritzsche, F, et al.
Publicado: (2006)

Secretome and degradome profiling shows that Kallikrein‐related peptidases 4, 5, 6, and 7 induce TGFβ‐1 signaling in ovarian cancer cells
por: Shahinian, Hasmik, et al.
Publicado: (2013)

Expression of kallikrein-related peptidase 7 is decreased in prostate cancer
por: Zhang, Chong-Yu, et al.
Publicado: (2015)

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
por: Kim, H, et al.
Publicado: (2001)

Prognostic significance of multiple kallikreins in high-grade astrocytoma
por: Drucker, Kristen L., et al.
Publicado: (2015)

Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors
por: Bronger, Holger, et al.
Publicado: (2019)

OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery
por: DORN, JULIA, et al.
Publicado: (2015)

Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Candido, Juliana B., et al.
Publicado: (2021)

Structure-Function Analyses of Human Kallikrein-related Peptidase 2 Establish the 99-Loop as Master Regulator of Activity
por: Skala, Wolfgang, et al.
Publicado: (2014)

The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
por: Yousef, G M, et al.
Publicado: (2002)

Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer
por: Du, Jian Ping, et al.
Publicado: (2018)

Prospective quantitative gene expression analysis of kallikrein-related peptidase KLK10 as a diagnostic biomarker for childhood acute lymphoblastic leukemia
por: Ahmad, Shwan Majid, et al.
Publicado: (2022)

A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity
por: Skala, Wolfgang, et al.
Publicado: (2016)

CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer
por: Seitz, Stefanie, et al.
Publicado: (2022)

CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
por: Bronger, Holger, et al.
Publicado: (2016)

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer
por: Chang, A, et al.
Publicado: (2002)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions
por: Avgeris, Margaritis, et al.
Publicado: (2011)

Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet-induced obesity by counteracting adipose tissue inflammation in vivo
por: Zieger, Konstanze, et al.
Publicado: (2017)

Development of Chemical Tools to Monitor Human Kallikrein 13 (KLK13) Activity
por: Gruba, Natalia, et al.
Publicado: (2019)

Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
por: Kidana, Kiwami, et al.
Publicado: (2018)

Transcriptome reveals the overexpression of a kallikrein gene cluster (KLK1/3/7/8/12) in the Tibetans with high altitude-associated polycythemia
por: Li, Kang, et al.
Publicado: (2017)

Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis
por: Bouzid, Hayet, et al.
Publicado: (2022)

Kallikrein 6 as a Serum Prognostic Marker in Patients with Aneurysmal Subarachnoid Hemorrhage
por: Martínez-Morillo, Eduardo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4225teehfqtq76262os8mu7naf